Skip to content

Study on Anti-Ageing product in both Indian males & females of 35 years to 60 years (both inclusive)

Study code: 2324CICL002, Version 1, Dated 01 Aug 2024; A CLINICAL STUDY TO EVALUATE THE ANTI-AGEING EFFICACY OF HUMAN GROWTH FACTORS AND CYTOKINES CONTAINING COSMETIC SKIN SERUM (VC GROF) IN BOTH MALES AND FEMALES WITH SENSITIVE SKIN - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074275
Enrollment
35
Registered
2024-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Cipla Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy male and female subjects with sensitive skin aged 35 years to 60 years’ old (both inclusive) 2. Fitzpatrick skin phototype III to VI 3. Subjects with minimum grade 2 of fine lines and wrinkles at crow’s feet, skin unevenness, density of pigmentary spots, cheek sebaceous pores as per Skin aging atlas, volume IV Indian skin type, by BAZIN & FLAMENT 4. Subjects not using fairness, skin, or spot lightening or antiaging or sunscreen creams/lotions (preferably about 60% non-users to be included) 5. Subjects not using any Vitamin C, retinol, niacinamide, glutathione, or any other serums/creams or supplements which might interfere with study assessments. 6. Subjects who have not undergone any aesthetic treatment (chemical peels, dermabrasion, lasers, Botox, fillers, etc.,) in the last 6 months and agreeing not to do in during the study period. 7. Subject free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face. 8. Subject who agrees not to use any other product/treatment on their face during the study period. 9. Subject who agrees not to carry out bleaching or any other procedures including facial etc. on face during the study period. 10. Subject to agree to remove all Jewellery on/around face (e.g., necklace, earrings, if possible, nose ring), during VISIA imaging. 11. Female subjects with child-bearing potential willing to undergo Urine Pregnancy Test and to use acceptable methods of contraception. 12. Subjects who can read, write and understand the informed consent document and willing to give a written informed consent. 13. Subjects ready to follow instructions and study restrictions during the study period.

Exclusion criteria

Exclusion criteria: 1. Subjects having known hypersensitivity to any of the study products or constituents. 2. Subjects who are pregnant or lactating or who are planning to become pregnant during the study (self-declared by subject on screening visit and test to be done on each evaluation visit except screening visit. 3. Participation in any other clinical trial up to 1 month prior to inclusion and during the study. 4. Subjects who have any significant skin pathology in the test area. 5. Subject who is currently taking any medication including food supplements, which the Investigator believes may influence the interpretation of the data. 6. Subject having chronic illness or had major surgery in the last year. 7. Subjects undergoing any treatment of any skin condition on their face/body. 8. Subjects having any allergy or sensitive to bar cleansing products, creams/lotions, artificial jewellery or anything else.

Design outcomes

Primary

MeasureTime frame
1.Clinical scoring of fine lines and wrinkles on forehead, crow’s feet wrinkles, Skin smoothness, skin suppleness, skin evenness, skin firmness, density of pigmentary spots & contrast of isolated pigmentary spot, skin radiance, ptosis and cheek sebaceous pores using Skin aging atlas Volume 4 Asian Skin Type by Dermatologists Investigator. Instrumental Evaluations: 2.Evaluation of skin crow’s feet wrinkles, forehead fine lines, wrinkles & cheek sebaceous pores using ANTERA 3D Device 3.Evaluation of skin & spot color using Chromameter CR400 4.Evaluation of Skin hydration using Corneometer CM 825®/MPA 6 5.Evaluation of TEWL using Tewameter TM 300/TM Hex 6.Evaluation of skin firmness using Cutometer MPA 580 Timepoint: D-14, D0, D28, D56 & D84

Secondary

MeasureTime frame
1. Evaluation of skin crow’s feet wrinkles, forehead fine lines, wrinkles & cheek sebaceous pores using ANTERA 3D Device 2. Evaluation of skin & spot color using Chromameter CR400 3. Evaluation of Skin hydration using Corneometer CM 825®/MPA 6 4. Evaluation of TEWL using Tewameter TM 300/TM Hex 5. Evaluation of skin firmness using Cutometer MPA 580 Timepoint: D-14, D0, D28, D56 & D84

Countries

India

Contacts

Public ContactAbhishek Kashyap

CIDP

p.kashyap@cidp-cro.com9089348156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026